Grupo Cibest S.A. CIB ← Back to all reports

Grupo Cibest S.A.

CIB · Financials
S ★★★★★ Strong Buy
Aug 13, 2026 · Score 95 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $96.70
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $90.00 ($85.00–$95.00)
Price TargetOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $110.00
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+13.8%

Type A - Grupo Cibest S.A. (CIB) 20260813 Stock Analysis

📅 Grupo Cibest Key Upcoming Events

🏢 Step 1: Grupo Cibest Company Overview & Business Model

Q1-A1. What is Grupo Cibest?

Q1-A2. How Does Grupo Cibest Make Money?

Q1-A3. Grupo Cibest’s Revenue Segments & Core Income Sources

Q1-A4. Who Are Grupo Cibest’s Competitors?

Q1-A5. Grupo Cibest Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: Grupo Cibest’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does Grupo Cibest Have a Durable Economic Moat?

Q2-A2. Is Grupo Cibest’s Growth Sustainable?

Q2-A3. How Does Grupo Cibest Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is Grupo Cibest Profitable? Financial Health Analysis

Q3-A2. How Profitable Is Grupo Cibest? (Margins & ROIC)

Q3-A3. What Drives Grupo Cibest’s Returns? (ROIC Breakdown)

Q3-A4. Are Grupo Cibest’s Earnings High Quality?

Q3-A5. Is Grupo Cibest’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: Grupo Cibest Forensic Accounting & Dilution Review

Q4-A1. Does Grupo Cibest Have Accounting Red Flags?

Q4-A2. Is Grupo Cibest Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is Grupo Cibest’s Cash Flow?

Q4-A4. Is Grupo Cibest Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: Grupo Cibest Management & Shareholder Alignment

Q5-A1. Can You Trust Grupo Cibest’s Management? (Guidance Track Record)

Q5-A2. What Are Grupo Cibest Insiders Doing?

Q5-A3. Is Grupo Cibest’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: Grupo Cibest Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Grupo Cibest Guidance

Q6-A2. What Is Grupo Cibest’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: Grupo Cibest Catalysts & Price Triggers

Q7-A1. What Could Move Grupo Cibest Stock? (Top 3 Catalysts)

Q7-A2. Grupo Cibest’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is Grupo Cibest Fairly Valued? Valuation Analysis

Q8-A1. Grupo Cibest’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. Grupo Cibest vs Peers: Valuation Comparison

Q8-A3. Is Grupo Cibest Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into Grupo Cibest? (Reverse DCF)

Q8-A4-1. What Growth Hurdle Does the Market Demand From Grupo Cibest? (Reverse DCF Alternative)

Q8-A5. Valuation Cross-Check

Q8-A6. Grupo Cibest’s Hidden Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of Grupo Cibest? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Grupo Cibest?

Q9-A2. How Sensitive Is Grupo Cibest to the Economy?

Q9-A3. Grupo Cibest Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score

🎯 Step 10: Grupo Cibest Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy Grupo Cibest? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. Grupo Cibest’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is Grupo Cibest’s Exposure to Colombia’s Fiscal Deficit Its Biggest Weakness?

Q2: Can Grupo Cibest’s 7.7x Forward P/E Be Justified by the Upcoming Central Bank Rate Cuts?

Q3: How Will Nequi’s Transition to an Independent Entity Rerate the Holding Company?

Q4: Does the Divestiture of Banistmo Prove the Efficacy of the New Corporate Structure?

Q5: Is the Wealth Tax Episode a Precursor to Persistent Regulatory Hostility?

Q6: Can the Bank Sustain Its Historic Net Interest Margin in a Stagnant Economy?

Q7: Does the Avista Colombia Acquisition Signal a Pivot Toward Higher-Risk Lending?

Q8: Will Aggressive Share Buybacks Compromise the Bank’s Capital Adequacy?

Q9: Is Banco Agrícola Disguising Weakness in the Broader Central American Portfolio?

Q10: Can the Bank Defend Its Market Share Against Neobank Aggression?

Rating History

Rating History shows the Rating assigned on each report date. We leave scores out of the timeline because reports from different periods may follow different rating scales. The score remains visible in each report that is still available.

  1. 2026-07 B
  2. 2026-08 S